VanEck Associates’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
10,749
+4,269
+66% +$119K ﹤0.01% 1287
2026
Q1
$237K Buy
6,480
+1,661
+34% +$65.5K ﹤0.01% 1251
2025
Q4
$220K Buy
4,819
+1,643
+52% +$73.2K ﹤0.01% 1272
2025
Q3
$134K Buy
3,176
+506
+19% +$19.1K ﹤0.01% 1311
2025
Q2
$83K Buy
+2,670
New +$72.3K ﹤0.01% 1311

Other funds holding AORT

VanEck Associates's AORT Position: Q2 2026 in Review

VanEck Associates increased its Artivion (AORT) stake by 66% in Q2 2026, buying an estimated $119K and bringing the position to 10,749 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

VanEck Associates first reported a position in AORT in Q2 2025 and has held it in 5 quarters since. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • VanEck Associates held 10,749 shares of Artivion worth $242K as of Q2 2026.
  • VanEck Associates bought 4,269 Artivion shares in Q2 2026, an estimated $119K.
  • Artivion made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1287 holding.
  • VanEck Associates first reported a position in Artivion in Q2 2025 and has held it in 5 quarters since.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.